Carrie Grace Causing

Title: Innovations of Carrie Grace Causing

Introduction

Carrie Grace Causing is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of neurogenesis and neuronal growth through her innovative research and inventions. With a total of 3 patents, her work has the potential to impact the understanding and treatment of neurological conditions.

Latest Patents

Carrie Grace Causing's latest patents include groundbreaking inventions related to DNA expression vectors. One of her patents, titled "Neuron promoter and uses," describes a DNA expression vector that comprises a Tαl α-tubulin promoter operatively linked upstream to a marker gene sequence. This invention is designed to be introduced into a mammal or its ancestor at an embryonic stage, with the promoter controlling the transcription of the marker gene. Additionally, the patent outlines a method for testing materials suspected of promoting neurogenesis and neuronal growth by exposing a transgenic mammal to the material and detecting the expressed marker gene as an indication of neurogenesis and neuronal growth. Another patent, "Tubulin promoter regulates gene expression in neurons," shares similar features and applications, further emphasizing her focus on advancing neurogenesis research.

Career Highlights

Carrie Grace Causing is affiliated with McGill University, where she conducts her research and develops her inventions. Her work at this prestigious institution has allowed her to collaborate with other leading researchers in the field.

Collaborations

Some of her notable coworkers include Freda Diane Miller and Andrew Gloster, who contribute to her research endeavors and help advance the understanding of neurogenesis.

Conclusion

Carrie Grace Causing's innovative work in the field of neurogenesis and her contributions through her patents highlight her role as a significant inventor. Her research has the potential to lead to new treatments and understanding of neurological conditions.